MUC5AC and cancer: The use of these two agents in a combination known as BromAc® has been shown to be a very effective mucolytic of pseudomyxoma peritonei (PMP) mucin [14,15], with anti-cancer effects on gastrointestinal (GI) cancer cells [16] and organoids [17].